Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Novartis Pharma

This page shows the latest Novartis Pharma news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

The latest from pharma, biotech and healthcare. Novartis joins big pharma’s antimicrobial research exodus. ... Novartis has become the latest big pharma company to exit anti-infectives research, dealing a blow to efforts to generate new products.

Latest news

  • The year of the blockbuster The year of the blockbuster

    Smart Thinking blog. Insights and expert advice on the key issues facing today’ s pharma marketer. ... Emanating from the pipelines of global pharma giants like Novartis, Johnson &Johnson and Pfizer, as well companies such as Denmark’s Novo Nordisk

  • Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

    Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report. ... Among the other predictions in the EP report are that Novartis will be the biggest pharma company by 2024, swapping places with Pfizer which will be competing with

  • Novartis bribery probe in Greece ‘could affect general election’ Novartis bribery probe in Greece ‘could affect general election’

    Novartis bribery probe in Greece ‘ could affect general election’. The pharma giant allegedly gave “bundles of cash”to civil servants, doctors and politicians. ... In the spotlight at the pharma company is ex-Novartis Greece vice president

  • Daily Brief: BIO takes over from ASCO, Greece's Novartis bribery case and more Daily Brief: BIO takes over from ASCO, Greece's Novartis bribery case and more

    Daily Brief: BIO takes over from ASCO, Greece's Novartis bribery case and more. ... Read the BIO schedule here. Greece’s Novartis bribery probe goes to the very top.

  • Daily Brief Daily Brief

    Daily Brief. A rapid round-up of the top pharma, biotech and healthcare news. ... Daniels’lawyer Michael Avenatti released documents showing AT&T and Novartis had both paid Cohen large sums of money for consultancy, with the Swiss pharma giant hiring

More from news
Approximately 6 fully matching, plus 150 partially matching documents found.

Latest Intelligence

  • Leo has its eyes on the prize Leo has its eyes on the prize

    We are in an era of great change and treatment advances, ”says Gitte Aabo, CEO and President of Leo Pharma. ... It makes it very attractive not only for Leo but for big pharma companies such as Novartis and Celgene that are very active in this area.

  • Can value-based healthcare take off and reach for the skies? Can value-based healthcare take off and reach for the skies?

    they do badly, ”added Mr Moran, who joined Novartis from McKinsey &Company as a strategic assistant to the CEO in January 2015. ... A one-off treatment, it comes with the hefty $475, 000 price tag - and a red rag to anti-pharma factions - but put

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    But in true pharma fashion, that leap was not without its side effects. ... What Novartis and all the other pharma companies are trying to do is distil the myriad content that they have available at their fingertips and transform it into something useful,

  • Are we #winning? Are we #winning?

    We’ve seen multiple online ‘TV’channels launch from medical societies and congress; some (eg ASCO) have commoditised their assets, and - for example, with Novartis’VivindaTV.com - pharma is now competing ... As this transformation continues at

  • Deal Watch December 2016 Deal Watch December 2016

    295. Novartis (Switzerland). Sun Pharma (India). Asset acquisition. Odomzo (sonidegib; hedgehog pathway inhibitor), approved in basal cell carcinoma. ... and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure deal, at $790m.

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    He most recently served as chief ethics, compliance and policy officer at Novartis, taking up the position in 2014 after a four-year stint as chairman of the board for Novartis ... Japan. Having first joined Novartis in 1997 as a general manager in The

  • UCB CEO elected to the Ministerial Industry Strategy Group UCB CEO elected to the Ministerial Industry Strategy Group

    Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies. ... Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of

  • Coulter Partners names head of Swiss office Coulter Partners names head of Swiss office

    Ernberg has had a varied career spending time at press agency Reuters, pharma company Novartis and humanitarian firm Vestergaard Frandsen.

  • Boehringer Ingelheim promotes Debraj Dasgupta Boehringer Ingelheim promotes Debraj Dasgupta

    Since joining the German pharma company in 2013 Dasgupta has oversaw customer insights across multiple therapy areas, including oncology, metabolism and immunology. ... Prior to this he spent nine years at Novartis in Switzerland where he led a number of

  • Alcon names president EMEA Alcon names president EMEA

    Dr Riad Sherif has left his role at Novartis in Canada to join the pharma giant's eyecare business Alcon as president for the EMEA region. ... He now heads the EMEA region for Alcon, which is the global leader in eyecare and is the second largest

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Experienced Healthcare Marketer Gareth Thurston, joins Cello Health Consulting

    Gareth has over 20 years’ experience in senior roles in a number of pharma companies, most recently at Novartis, where he spent seven years in various roles, including Brand Lead Opthalmology, ... biggest pharma companies.” Gareth will be based at

  • Marketing strategy in complex environments

    Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines. ... The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment.

  • How do you define a biotech company?

    Johnson &Johnson and Pfizer are two of the largest pharma companies in the world by revenue but both have numerous biological therapies. ... This approach is particularly apparent in some of the recent examples of technology pioneered by biotech

  • GEM Marketing Ltd

    Our clients include:. AbbVie. Amgen. Gilead. Martindale Pharma. Menarini. Merck. Novartis.

  • GEM Marketing Ltd

    Our clients include:. AbbVie. Amgen. Gilead. Martindale Pharma. Menarini. Merck. Novartis.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Quick links

Infographics

Multimedia